Accueil › Leucémie lymphocytaire chronique › Caroline du Nord › Durham
Essais cliniques pour Leucémie lymphocytaire chronique à Durham, NC
27 études pour Leucémie lymphocytaire chronique recherchent des participants dans et autour de Durham (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Recrutement en coursPhase 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · à 10 mi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Durham VA Medical Center, Durham
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Recrutement en coursPhase 3
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · à 10 mi
- University of North Carolina-Hillsborough Campus, Hillsborough · à 13 mi
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Recrutement en coursPhase 3
- University of North Carolina At Chapel Hill, Chapel Hill · à 10 mi
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Recrutement en coursPhase 3
- Duke University Medical Center, Durham
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Recrutement en coursPhase 3
- Duke University Medical Center, Durham
- University of North Carolina At Chapel Hill, Chapel Hill · à 10 mi
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Recrutement en coursPhase 3
- Duke University, Durham
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Recrutement en coursPhase 2
- Duke University, Durham
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia
Recrutement en coursPhase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · à 10 mi
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Recrutement en coursPhase 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · à 10 mi
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Recrutement en coursPhase 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · à 10 mi
Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
Recrutement en coursPhase 2
- Research Site, Durham
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
Recrutement en coursPhase 1
- University of North Carolina at Chapel Hill, Chapel Hill · à 10 mi
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Recrutement en coursPhase 1
- Duke University Medical Center, Durham
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Recrutement en cours
- North Carolina Basnight Cancer Hospital, Chapel Hill · à 10 mi
Registry of Older Patients With Cancer
Recrutement en coursÉtude observationnelle
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · à 10 mi
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Recrutement en coursPhase 1
- University of North Carolina, Chapel Hill · à 10 mi
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Recrutement en coursPhase 4
- Duke University Medical Center, Durham
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Recrutement en coursPhase 4
- Duke University Medical Center, Durham
Study of SGR-1505 in Mature B-Cell Neoplasms
Recrutement en coursPhase 1
- Duke University, Durham
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Recrutement en coursPhase 2
- University of North Carolina /ID# 233313, Chapel Hill · à 10 mi
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
Recrutement en coursPhase 2
- The University of North Carolina at Chapel Hill, Chapel Hill · à 10 mi
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Recrutement en coursPhase 1
- Duke University, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recrutement en coursÉtude observationnelle
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · à 10 mi
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Recrutement en coursPhase 2
- Durham VA Medical Center, Durham, NC, Durham
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Recrutement en coursPhase 1
- University of North Carolina, Chapel Hill · à 10 mi
CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
Recrutement en coursPhase 1
- Duke University, Durham
Essais pour Leucémie lymphocytaire chronique dans d'autres villes
- Boston, MA31 études
- Columbus, OH28 études
- Washington, DC22 études
- Seattle, WA20 études
- Rochester, MN19 études
- New York City, NY18 études
- Houston, TX17 études
- Baldwin Park, CA16 études
- Milwaukee, WI15 études
- Cincinnati, OH14 études
- Chicago, IL14 études
- Nashville, TN13 études
Autres études à Durham
- Cancer du sein63 études
- Cancer (tous types)58 études
- Cancer du poumon non à petites cellules39 études
- Myélome multiple37 études
- Cancer métastatique33 études
- Leucémie aiguë myéloïde33 études
- Cancer du poumon32 études
- Cancer de la prostate32 études
- Cancer colorectal28 études
- Cancer de l'ovaire27 études
- Insuffisance cardiaque26 études
- Cancer du pancréas24 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.